Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69,035 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, Xu W, Zhao Y, Li N, Zhang J, Liang H, Bao L, Xu Y, Ding L, Zhou W, Gao H, Liu J, Niu P, Zhao L, Zhen W, Fu H, Yu S, Zhang Z, Xu G, Li C, Lou Z, Xu M, Qin C, Wu G, Gao GF, Tan W, Yang X. Wang H, et al. Among authors: yang x. Cell. 2020 Aug 6;182(3):713-721.e9. doi: 10.1016/j.cell.2020.06.008. Epub 2020 Jun 6. Cell. 2020. PMID: 32778225 Free PMC article.
Cryo-EM structure of the varicella-zoster virus A-capsid.
Sun J, Liu C, Peng R, Zhang FK, Tong Z, Liu S, Shi Y, Zhao Z, Zeng WB, Gao GF, Shen HJ, Yang X, Luo M, Qi J, Wang P. Sun J, et al. Among authors: yang x. Nat Commun. 2020 Sep 22;11(1):4795. doi: 10.1038/s41467-020-18537-y. Nat Commun. 2020. PMID: 32963252 Free PMC article.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X. Xia S, et al. Among authors: yang x, yang y. Lancet Infect Dis. 2021 Jan;21(1):39-51. doi: 10.1016/S1473-3099(20)30831-8. Epub 2020 Oct 15. Lancet Infect Dis. 2021. PMID: 33069281 Free PMC article. Clinical Trial.
Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate.
Zhang XY, Guo J, Wan X, Zhou JG, Jin WP, Lu J, Wang WH, Yang AN, Liu DX, Shi ZL, Yuan ZM, Li XG, Meng SL, Duan K, Wang ZJ, Yang XM, Shen S. Zhang XY, et al. Among authors: yang xm, yang an. Emerg Microbes Infect. 2020 Dec;9(1):2653-2662. doi: 10.1080/22221751.2020.1855945. Emerg Microbes Infect. 2020. PMID: 33232205 Free PMC article.
Identifying Potential Candidate Hub Genes and Functionally Enriched Pathways in the Immune Responses to Quadrivalent Inactivated Influenza Vaccines in the Elderly Through Co-Expression Network Analysis.
Yang J, Zhang J, Fan R, Zhao W, Han T, Duan K, Li X, Zeng P, Deng J, Zhang J, Yang X. Yang J, et al. Among authors: yang x. Front Immunol. 2020 Dec 4;11:603337. doi: 10.3389/fimmu.2020.603337. eCollection 2020. Front Immunol. 2020. PMID: 33343577 Free PMC article. Clinical Trial.
The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.
Wu J, Zhang L, Zhang Y, Wang H, Ding R, Nie J, Li Q, Liu S, Yu Y, Yang X, Duan K, Qu X, Wang Y, Huang W. Wu J, et al. Among authors: yang x. Front Immunol. 2021 Jun 17;12:687869. doi: 10.3389/fimmu.2021.687869. eCollection 2021. Front Immunol. 2021. PMID: 34220844 Free PMC article.
69,035 results
You have reached the last available page of results. Please see the User Guide for more information.